Compounds > vancomycin
Page last updated: 2024-08-21

vancomycin and furazolidone

vancomycin has been researched along with furazolidone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Finegold, SM1
Cox, MP; Olivera, C; Rakonjac, J; Rowlands, GJ1
Le, VVH; Olivera, C; Rakonjac, J; Wykes, H1
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Ekins, S; Williams, AJ; Xu, JJ1

Other Studies

7 other study(ies) available for vancomycin and furazolidone

ArticleYear
Interaction of antimicrobial therapy and intestinal flora.
    The American journal of clinical nutrition, 1970, Volume: 23, Issue:11

    Topics: Anti-Bacterial Agents; Antifungal Agents; Bacitracin; Bacteria; Chloramphenicol; Enterobacteriaceae; Erythromycin; Furazolidone; Glycosides; Humans; Intestine, Large; Lincomycin; Nalidixic Acid; Novobiocin; Penicillins; Polymyxins; Sulfonamides; Tetracycline; Vancomycin

1970
Correlated Transcriptional Responses Provide Insights into the Synergy Mechanisms of the Furazolidone, Vancomycin, and Sodium Deoxycholate Triple Combination in Escherichia coli.
    mSphere, 2021, 10-27, Volume: 6, Issue:5

    Topics: Anti-Bacterial Agents; Deoxycholic Acid; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Escherichia coli; Furazolidone; Vancomycin

2021
When less is more: shortening the Lpp protein leads to increased vancomycin resistance in Escherichia coli.
    The Journal of antibiotics, 2023, Volume: 76, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Escherichia coli; Escherichia coli Proteins; Furazolidone; Humans; Lipoproteins; Microbial Sensitivity Tests; Vancomycin; Vancomycin Resistance

2023
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4

    Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen

2007
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010